MD ANDERSON CANCER CENTER and AbbVie formed a three-year collaboration to perform preclinical and clinical studies evaluating immuno-oncology therapies. AbbVie and MD Anderson will each assign two scientists to a joint scientific committee, which will decide on which projects to pursue. The collaboration will begin with projects driven by AbbVie Biotherapeutics. Future projects will draw...
With NCI Director Anthony Letai in Milan supporting his daughter, Julie, at the 2026 Winter Olympics, Douglas R. Lowy, principal deputy director of NCI, took on the job of delivering detailed remarks and fielding questions at the inaugural meeting of the NCAB’s ad hoc working group on Extramural Research Concepts and Programs.
